Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Lucy Scientific Discovery Inc. (LSDIF) vs PainReform Ltd. (PRFX)

Lucy Scientific Discovery Inc. and PainReform Ltd. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $3.0M against $900.0K — 3.3× the size. Across the 7 metrics below, Lucy Scientific Discovery Inc. leads on 4 and PainReform Ltd. on 3.

Valuation

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m n/m 2.25
P/B n/m 0.00 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.99 12.29
EV/Sales n/m n/m 2.56
Earnings yield 0.00% (61,696.04%) (2.99%)
Free cash flow yield 0.00% (80,633.63%) 0.00%

Profitability

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 0.00% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 337.20% 0.00% (0.40%)
Return on assets (249.36%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — — 10.01%
EPS growth (last fiscal year) (4.46%) 92.92% —
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 0.38 5.07 2.31
Net debt to EBITDA 0.05 0.96 0.85

Dividend

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric LSDIF PRFX Drug Manufacturers Specialty & Generic median
Market cap 900.00k 2.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack